Europe Patient Monitoring Devices Market Size & Share Analysis - Growth, Trends & Forecasts (2025 - 2030)

Europe Patient Monitoring Devices Market Analysis

The Europe Patient Monitoring Devices Market size is estimated at USD 1.36 billion in 2025, and is expected to reach USD 3.17 billion by 2030, at a CAGR of 18.42% during the forecast period (2025-2030).

The major factors driving the market growth include the rising burden of chronic diseases due to lifestyle changes and the growing preference for home and remote monitoring. Patients undergoing chemotherapy or radiation therapy may use devices to monitor vital signs and blood counts to manage side effects and treatment response. For instance, according to the data updated by the Santé Publique France in July 2023, an estimated 433 thousand new cancer diagnoses occured in France in 2023. The source also stated that new cancer cases in women are increasing faster, with the median age of diagnosis being 68 years old (compared to 70 years old for men). Also, as per the same source, the top three most prevalent forms of cancer in men were prostate, lung, and colorectal, respectively. Similarly, breast cancer was the most prevalent form of cancer in women, followed by colorectal and lung cancer.

In addition, patients with hypertension, arrhythmias, and heart failure can benefit from devices like blood pressure monitors, electrocardiogram (ECG) monitors, and wearable heart rate monitors to keep track of their heart health. For instance, according to the data released by the British Heart Foundation in September 2024, currently, 7.6 million people are living with a heart or circulatory disease in the United Kingdom. As per the same source, around 80 percent of people with heart and circulatory diseases have at least one other health condition. Thus, the region's high prevalence of heart disease is projected to drive the adoption of patient monitoring devices during the forecast period.

Furthermore, the increasing number of fundings and partnerships by prominent players is projected to drive market growth during the forecast period. For instance, in November 2023, Bertelsmann Investments (BI) invested USD 5.59 million in Doccla, a European provider of virtual hospital platform for telemonitoring. This funding helps Doccla improve its technology, making remote patient monitoring at home more effective and user-friendly. With better resources, Doccla can expand its reach across Europe, making healthcare more accessible, especially for people in remote areas. The investment also supports research and development to innovate and refine their services, leading to better patient outcomes through timely interventions.

Similarly, in September 2024, Nonin Medical, known for its SpO₂ monitoring solutions, collaborated with Corscience, a German specialist in CO₂ monitoring, to jointly promote their patient monitoring technologies. By promoting each other's OEM products, both companies aim to use their unique strengths to meet the rising demands of healthcare providers. Through this partnership, Nonin expands its portfolio to include CO₂ monitoring, and Corscience adds advanced SpO₂ technology to its range. This collaboration leads to integrated solutions, improving patient care, optimizing clinical workflows, and potentially lowering costs for healthcare facilities. Such initiatives by key players are projected to boost the market growth in the Europe.

Therefore, factors such as the rising prevalence of chronic diseases and increasing number of fundings and partnerships by prominent players are projected to drive market growth during the forecast period. However, regulatory challenges and data security concerns may restrain the market growth during the forecast period.

Europe Patient Monitoring Devices Market Trends

The Weight Management and Fitness Monitoring Segment is Expected to Register a Significant Share of the Market Over the Forecast Period

Europe Patient Monitoring Devices Industry Segmentation

As per the scope of the report, patient monitoring devices are devices that continuously monitor the patient’s vital parameters, like blood pressure and heart rate, by using a medical monitor and collecting medical (and other) data from individuals. The Europe patient monitoring devices market is segmented into type of device, application, and geography. By type of devices, the markey is segmented into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices, multi-parameter monitors, respiratory monitoring devices, and other types of devices. The other types of devices segment includes fetal and neonatal monitoring devices and temeperature monitoring devices. By application, the market is segmented into cardiology, neurology, respiratory, fetal and neonatal, weight management and fitness monitoring, and other applications. The other application segment includes diabetes and infections, among others. By geography, the market is segmented into Germany, United Kingdom, France, Italy, Spain, and Rest of Europe. The report offers the value (in USD) for the above segments.